Brokerages Anticipate Genpact Limited (G) to Announce $0.47 EPS

Wall Street brokerages expect that Genpact Limited (NYSE:G) will report earnings of $0.47 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Genpact’s earnings. The lowest EPS estimate is $0.45 and the highest is $0.48. Genpact posted earnings of $0.41 per share during the same quarter last year, which suggests a positive year over year growth rate of 14.6%. The company is expected to report its next earnings report on Tuesday, August 6th.

On average, analysts expect that Genpact will report full-year earnings of $1.99 per share for the current fiscal year, with EPS estimates ranging from $1.96 to $2.01. For the next financial year, analysts anticipate that the company will report earnings of $2.25 per share, with EPS estimates ranging from $2.22 to $2.28. Zacks’ EPS averages are an average based on a survey of research firms that that provide coverage for Genpact.

Genpact (NYSE:G) last issued its earnings results on Thursday, May 2nd. The business services provider reported $0.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.07. The business had revenue of $809.21 million during the quarter, compared to analyst estimates of $764.50 million. Genpact had a return on equity of 23.03% and a net margin of 8.91%. Genpact’s revenue for the quarter was up 17.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.39 earnings per share.

A number of analysts have recently weighed in on G shares. Cantor Fitzgerald reissued a “buy” rating and set a $36.00 price objective on shares of Genpact in a research note on Sunday, March 3rd. Bank of America raised Genpact from an “underperform” rating to a “buy” rating and set a $36.00 price objective for the company in a research note on Wednesday, February 6th. ValuEngine raised Genpact from a “hold” rating to a “buy” rating in a research note on Friday, March 29th. Zacks Investment Research raised Genpact from a “sell” rating to a “hold” rating in a research note on Tuesday, April 2nd. Finally, Wells Fargo & Co raised Genpact from a “market perform” rating to an “outperform” rating and set a $33.25 price objective for the company in a research note on Friday, March 8th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Genpact currently has an average rating of “Buy” and a consensus price target of $33.97.

Shares of G opened at $35.10 on Friday. The company has a market capitalization of $6.86 billion, a price-to-earnings ratio of 21.94, a PEG ratio of 1.97 and a beta of 0.87. The company has a quick ratio of 1.39, a current ratio of 1.39 and a debt-to-equity ratio of 0.69. Genpact has a 1 year low of $25.48 and a 1 year high of $37.70.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Wednesday, June 12th will be issued a dividend of $0.085 per share. The ex-dividend date of this dividend is Tuesday, June 11th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.97%. Genpact’s dividend payout ratio is presently 21.25%.

In related news, CEO N. V. Tyagarajan sold 133,625 shares of the company’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $35.95, for a total transaction of $4,803,818.75. Following the completion of the transaction, the chief executive officer now owns 617,516 shares in the company, valued at $22,199,700.20. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Private Ltd Gic sold 1,499,806 shares of the company’s stock in a transaction that occurred on Friday, February 15th. The shares were sold at an average price of $32.22, for a total value of $48,323,749.32. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,889,065 shares of company stock valued at $61,929,338. 1.86% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in the stock. Bremer Trust National Association bought a new position in Genpact in the fourth quarter worth $36,000. Bremer Bank National Association bought a new position in Genpact in the first quarter worth $38,000. New York State Teachers Retirement System bought a new position in Genpact in the first quarter worth $77,000. Neuburgh Advisers LLC bought a new position in Genpact in the first quarter worth $123,000. Finally, Sit Investment Associates Inc. raised its holdings in Genpact by 19.5% in the fourth quarter. Sit Investment Associates Inc. now owns 5,675 shares of the business services provider’s stock worth $153,000 after purchasing an additional 925 shares in the last quarter. Institutional investors own 95.84% of the company’s stock.

About Genpact

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

Read More: Intrinsic Value

Get a free copy of the Zacks research report on Genpact (G)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.